Morning News

Partners Group Takes Legal Action Against U.S. Investor Grizzly Research

By Nadine PEREIRA
Published on Tue, 26.May.2026

Topic of the day

The Zug-based investment firm Partners Group intends to take legal action against the U.S. investment firm Grizzly Research. This was announced by Chairman of the Board Steffen Meister in an interview with the “NZZ am Sonntag.” In a report released in late April, Grizzly Research had circulated serious allegations against Partners Group. “We have decided to take legal action against those responsible at Grizzly Research,” said Meister. The report claimed, for example, that Partners Group was “worse than Wirecard”—one of the biggest fraud cases in German economic history. Grizzly and its allies, who specialize in short selling, profited from the drop in Partners Group’s stock price following the publication of the report, the newspaper writes.

Swiss stocks

The Swiss stock market edged up on Friday, with a gain of 0.4 percent to 13,503 points. Trading on the Swiss stock exchange will be suspended on May 26 (Monday of Pentecost). Cyclical stocks were among the leaders amid hopes for a swift end to the Middle East conflict. Sika rose by 3.0 percent, Givaudan by 2.3 percent, and Holcim by 2.0 percent. Partners Group shares ranked at the very bottom of the SMI. These dropped by 4.6 percent to 41.20 francs. However, shares were traded ex-dividend. The asset management expert paid out 46 francs per share. Richemont shares slipped 0.6 percent. The Cartier owner reported accelerated revenue growth for its latest quarter, despite the headwinds from the Middle East conflict. Among smaller caps, Julius Bär plummeted by 6.9 percent. During its earnings presentation, the bank had reported a slowdown in client inflows at the beginning of the year. Within the SMI, the share price of its significantly larger competitor, UBS, gained ground.

International markets

Europe
On Monday, U.S.-Iran tensions weighed on oil prices and long-term interest rates. The Stoxx Europe 600 index climbed 1% to 631.63 points. In Paris, the CAC 40 and the SBF 120 advanced 1.8% and 1.7%, respectively. In Frankfurt, the DAX 40 jumped 2% The London Stock Exchange and U.S. markets were closed on Monday for the Spring Bank Holiday and Memorial Day, respectively. The sharp drop in oil prices benefited airline stocks such as Air France-KLM (+6.2% in Paris) and Lufthansa (+3.6% in Frankfurt), while oil company stocks, including TotalEnergies (-1.25%), lost ground. The tourism sector, including Accor (+3.1%), was in demand. ABIVAX (+8.7%): The biotechnology company reported on Friday evening a loss for the first quarter of this year due to higher research and development costs yet indicated maintaining ample cash reserves to fund operations through the end of 2027. NANOBIOTIX (+0.5%): The biotechnology company revealed on Friday evening that the underwriters for its previously announced global offering had fully exercised their over-allotment option, bringing the total proceeds from its capital increase to $100 million, or approximately €86.1 million.

United States
U.S. markets were closed on Monday for Memorial Day.

Asia
Asian stock markets are trading mixed on Tuesday, following the broadly positive cues from European markets and lack of cues from Wall Street overnight, amid renewed uncertainty about a potential peace deal to end the Middle East conflict after the US attacked key Iranian missile launch sites in Southern Iran and boats attempting to lay mines, in what Iran said were defensive actions. The benchmark Nikkei 225 Index closed the morning session at 64,897.64, down 260.55 points or 0.40 percent. Elsewhere in Asia, South Korea is up 3.2 percent, while New Zealand, Hong Kong and Indonesia are higher by between 0.3 and 1.0 percent each. China, Singapore, Malaysia and Taiwan are lower by between 0.1 and 0.4 percent each.

Bonds
U.S. markets were closed on Monday for Memorial Day. The 10-year Canadian government bond yield fell 6.57 basis points to 3.469%.

Analysis
Jefferies raises Sonova target to CHF 170 (155) – Underperform
Deutsche Bank increases Kühne + Nagel target to CHF 183 (180) – Hold
Deutsche Bank raises SoftwareOne target to CHF 8.50 (7.55) – Hold

Produced by MBI Martin Brückner Infosource GmbH & Co. KG on behalf of Swissquote. All news is acquired with journalistic accuracy. No liability is assumed for delays or errors.

Follow us
Be in the know

Sign up to our newsletter and receive a monthly selection right in your inbox


Sponsors
UEFA Europa LeagueGenève ServetteZSC Lions

General Information
This website is operated jointly by Swissquote MEA Ltd. (“SQMEA”) and Swissquote Bank SA’s Representative Office in Dubai (the “Swissquote Representative Office”). SQMEA is incorporated in the Dubai International Financial Centre (“DIFC”) and regulated by the Dubai Financial Services Authority (“DFSA”). The Swissquote Representative Office is licensed by the Central Bank of the United Arab Emirates to carry out representative office activities only. Swissquote Bank SA (“SQB”) is incorporated in Switzerland and regulated by the Swiss Financial Market Supervisory Authority (FINMA).
 
Depending on the section of the website, products and services presented may be promoted by SQMEA or by the Swissquote Representative Office. In particular, SQMEA does not promote, arrange or offer to Retail Clients access to any services relating to contracts for differences (CFDs), rolling spot foreign exchange, or other Restricted Speculative Investments, as defined in the DFSA Rulebook (www.dfsa.ae).
 
SQMEA operates multiple business lines. For the target audience of this website, all products and services presented are offered by SQB.
 
No Offer or Advice
The content of this website is provided for information purposes only and does not constitute investment advice, a recommendation, a solicitation, or an offer to buy or sell any financial instruments.
Nothing on this website should be relied upon as the sole basis for making investment decisions. Visitors should seek independent financial, legal, and tax advice before making any investment.
 
Product Availability and Eligibility
Access to products and services described on this website is subject to applicable laws, regulations, and eligibility requirements.
Certain products or services may not be available in all jurisdictions or to all clients, and additional conditions or restrictions may apply.
 
Risk Warning
Investing in financial instruments involves risk, including the possible loss of capital. Past performance is not a reliable indicator of future results.
Further information is available in the “Risks Involved in Trading Financial Instruments” disclosure.
 
AI-Generated Content
Some visual or editorial content on this website may be generated or enhanced using artificial intelligence (AI) tools.
All such content is subject to human review and approval to ensure accuracy, appropriateness, and compliance with applicable regulatory requirements. AI is not used to provide personalised investment advice, suitability assessments, or client-specific recommendations.